Loading...
•
Jan 02, 2021
Masimo Q4 2020 Earnings Report
Announced financial results for the fourth quarter and full-year ended January 2, 2021.
Key Takeaways
Masimo reported a 19.2% increase in total revenue for the fourth quarter of 2020, reaching $295.1 million compared to $247.5 million in the fourth quarter of 2019. GAAP net income per diluted share was $1.21, and non-GAAP net income per diluted share was $0.98.
Product revenue increased 19.2% to $295.1 million, or 18.1% on a constant currency basis.
GAAP net income per diluted share was $1.21.
Non-GAAP net income per diluted share was $0.98.
Shipments of noninvasive technology boards and instruments increased 35.2% to 83,000, excluding handheld and fingertip pulse oximeters.
Masimo
Masimo
Forward Guidance
The Company provided the following estimates for its full-year 2021 guidance:
Positive Outlook
- Product revenue increasing to $1.200 billion, which reflects reported growth of 4.9% and constant currency growth of 3.6%;
- GAAP diluted earnings per share increasing to $3.81;
- Non-GAAP diluted earnings per share increasing to $3.80;
- Included in our full-year 2021 revenue guidance is approximately $15.0 million of year-over-year currency tailwinds.